2022
DOI: 10.1016/j.clineuro.2022.107305
|View full text |Cite
|
Sign up to set email alerts
|

Plasma osteoprotegerin level is associated with hemorrhagic transformation in stroke patients who underwent endovascular thrombectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 55 publications
0
1
0
Order By: Relevance
“…Moreover, elevated levels of OPG have been found to be associated with incident [10,11,28], severity at admission [10,27,28], poor functional outcome [9,13,14] and mortality [9,15,16] following an IS event. This association is supported by evidence linking elevated plasma OPG levels to vulnerable carotid plaques [29], larger infarctions [13], higher National Institutes of Health Stroke Scale scores at admission [13] and the occurrence and severity of hemorrhagic transformation [30]. The potential mechanisms by which OPG may be linked to the development of inflammatory diseases such as atherosclerosis are multifaceted.…”
Section: Plos Onementioning
confidence: 89%
“…Moreover, elevated levels of OPG have been found to be associated with incident [10,11,28], severity at admission [10,27,28], poor functional outcome [9,13,14] and mortality [9,15,16] following an IS event. This association is supported by evidence linking elevated plasma OPG levels to vulnerable carotid plaques [29], larger infarctions [13], higher National Institutes of Health Stroke Scale scores at admission [13] and the occurrence and severity of hemorrhagic transformation [30]. The potential mechanisms by which OPG may be linked to the development of inflammatory diseases such as atherosclerosis are multifaceted.…”
Section: Plos Onementioning
confidence: 89%
“…The pathway of RANK (receptor activator of nuclear factor kappa B) – RANKL (RANK ligand) – OPG (osteoprotegerin) is recognized for its function in bone remodeling, where RANKL/RANK signaling controls the formation, activation, and survival of osteoclasts during regular bone modeling and remodeling. OPG inhibits osteoclast activation through the RANK receptor by binding to RANKL and increases bone volume and density ( 31 , 32 ). Oral inflammation produces pro-inflammatory cytokines, which are osteoclastogenic bone resorption-inducing cytokines.…”
Section: Discussionmentioning
confidence: 99%